Article
Review Article
Ann Lab Med 2016; 36(2): 85-100
Published online March 1, 2016 https://doi.org/10.3343/alm.2016.36.2.85
Copyright © Korean Society for Laboratory Medicine.
Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways
Rolf Marschalek, Ph.D.
Institute of Pharmaceutical Biology/DCAL, Goethe-University of Frankfurt, Biocenter, Frankfurt/Main, Germany
Correspondence to: Rolf Marschalek
Institute of Pharmaceutical Biology, University of Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt/Main, Germany
Tel: +49-69-798-29647
Fax: +49-69-798-29662
E-mail: Rolf.Marschalek@em.uni-frankfurt.de
Chromosomal translocations of the human mixed-lineage leukemia (MLL) gene have been analyzed for more than 20 yr at the molecular level. So far, we have collected about 80 direct MLL fusions (MLL-X alleles) and about 120 reciprocal MLL fusions (X-MLL alleles). The reason for the higher amount of reciprocal MLL fusions is that the excess is caused by 3-way translocations with known direct fusion partners. This review is aiming to propose a solution for an obvious problem, namely why so many and completely different MLL fusion alleles are always leading to the same leukemia phenotypes (ALL, AML, or MLL). This review is aiming to explain the molecular consequences of MLL translocations, and secondly, the contribution of the different fusion partners. A new hypothesis will be posed that can be used for future research, aiming to find new avenues for the treatment of this particular leukemia entity.
Keywords: MLL-r leukemia, Translocation partner genes, Molecular mechanisms of cancer
